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In recent years neurodegenerative diseases deserved growing
attention for the progressive lengthening of human survival
and the increasing prevalence of age-related brain disorders.
Increasing competence is required by clinicians in regard
to the different aspects of these chronic disabling disorders,
as psychiatric and cognitive aspects, motor impairment,
and pain. Diseases as dementia and motoneuronal and
extrapyramidal disorders are opening a new scenario on pain
syndromes, which represent an underestimated problem as
the link between pathology and the pain experience is most
often difficult to establish. This special issue was hosted by
a panel of pain specialists around Europe and Israel, who
shared common scientific interests on different aspects of
pain, being particularly involved in researches on pain assess-
ment and diagnosis in neurodegenerative diseases and espe-
cially dementia.
The issue contains a comprehensive review on pain
aspects in common and rare neurodegenerative disorders
where pain has recently emerged as a frequent symptom,
although main treatments are exclusively focusing on cog-
nitive or motor impairment and hence leave pain out of
the guidelines. In Alzheimer disease, pain symptoms are not
clearly expressed, so the few clinical scales actually used and
in course of validation have the special aim to recognize
features of sufferance. In Parkinson’s disease and amyotrophic
lateral sclerosis, pain has been described as a frequent associ-
ated condition, while few specific scales were employed and
pain treatment is not guided by any quantitative assessments.
In the review, the search for studies assessing the frequency
and the clinical features of pain in these syndromes leads to
the conclusion that it is a poorly studied symptom, despite
its potential impact on the outcome of the diseases and main
implication on the patients’ quality of life. Up to now the
available studies on the pathophysiological basis of pain in
these disorders are inconclusive, and only few indications are
present in regard to guiding the pharmacological approaches.
The review outlined the need of a more focused attention by
clinicians and researches on this emerging problem in the
management of neurodegenerative diseases and the use of
quantitative tools to evaluate the pain symptoms.
In addition, someoriginal articles have also been included
in this special issue to support this concept.
Since the first reports of altered pain responses in patients
with cognitive impairment were published, the question has
arisen, whether there might be certain cognitive domains
(e.g., memory, attention, and executive functioning) that
might best explain these alterations in pain responses. Kunz
et al. [1] previously investigated this in a group of patients
suffering from either mild cognitive impairment or dementia
and found that “executive functioning” was the cognitive
domain that best explained dementia-related alterations in
pain responsiveness. In the present special issue, J. M. Oost-
erman et al. followed this approach and investigated which
role executive functioning plays in explaining variations
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in self-report and facial expression to pain in a group of
52 older individuals. Facial expression and self-report were
assessed in response to pressure pain of different intensities
and these pain responses were then related to different
domains of cognitive functioning. The authors could show
that executive functioning (especially cognitive inhibition)
indeed played an important role in explaining variations
in pain responsiveness in older individuals. The poorer the
ability for cognitive inhibition was, the stronger the facial
expressions of pain across pain intensities were. Or in other
words, impairment in executive functioning leads to a more
pronounced communication of pain via the face. This study
highlights the need to include tests of cognitive functions
when assessing pain in older individuals.
T. F. Habiger et al. examined the complex relationship
between pain, neuropsychiatric symptoms, and agitation in
people with dementia. The authors performed a cluster ran-
domized controlled trial and showed that in nursing homes
patients with dementia exhibited reduced agitation, aberrant
motor behaviour, and psychosis when they received pain
treatment. This important trial suggests that pain is linked
to psychosis and agitation among patients with dementia. In
addition, the authors showed that opioid analgesics did not
increase the prevalence of hallucination or delusion. These
observations are particularly pivotal to provide adequate pain
care in this vulnerable population.
M. W. de Vries et al. provided a good example of the dif-
ficulties of pain assessment in patients with cognitive impair-
ment and their possible solution. They studied 153 patients
with moderate to severe cognitive impairment by using the
Orofacial Pain Scale for Non-Verbal Individuals (OPS-NVI).
The “chewing” subscale was demonstrated to be reliable in
assessing orofacial pain by means of the mere observation
of video clips. Orofacial pain can be extremely frequent in
elderly patients who have lost the capability to express it.
Therefore, the development of behavioural scales able to
reveal pain in these patients is mandatory to improve their
quality of life. Of course, these tools need to prove their
efficacy in large samples of patients, such as that investigated
in this study.
Finally, one study by M. de Tommaso et al. reports orig-
inal data on pain assessment in a rare disease such as Hunt-
ington’s disease (HD). In HD motor symptoms as dystonia
and hyperkinesis may be a potential cause of pain, but this
has been only rarely reported in such disorder, suggesting a
substantial dysfunction in pain expression.The present study
reports the results of the application of a neurophysiological
method as laser evoked potentials (LEPs) in earlyHDpatients
and genetically predisposed subjects in a presymptomatic
phase. The LEPs showed clear abnormalities in both patients
and those presymptomatic subjects who approached clinical
onset, suggesting that the dysfunction of pain pathways is
an early phenomenon which can influence sensory motor
integration and the global outcome of the disease.
In conclusion, this special issue adds a small but poten-
tially useful piece to the puzzle of pain expression and pain
treatment in patients with cognitive and communication dis-
orders, contributing to the understanding and management
of the complex clinical aspects of pain in neurodegenerative
diseases, a field which should receive more attention in the
future.
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